Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma

Small hepatocellular carcinoma (sHCC) is a special subtype of HCC with the maximum tumor diameter ≤ 3 cm and excellent long-term outcomes. Surgical resection or radiofrequency ablation provides the greatest chance for cure; however, many patients still undergo tumor recurrence after primary treatmen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC cancer 2020-06, Vol.20 (1), p.607-607, Article 607
Hauptverfasser: Ling, Yi-Hong, Chen, Jie-Wei, Wen, Shi-Hong, Huang, Chao-Yun, Li, Peng, Lu, Liang-He, Mei, Jie, Li, Shao-Hua, Wei, Wei, Cai, Mu-Yan, Guo, Rong-Ping
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 607
container_issue 1
container_start_page 607
container_title BMC cancer
container_volume 20
creator Ling, Yi-Hong
Chen, Jie-Wei
Wen, Shi-Hong
Huang, Chao-Yun
Li, Peng
Lu, Liang-He
Mei, Jie
Li, Shao-Hua
Wei, Wei
Cai, Mu-Yan
Guo, Rong-Ping
description Small hepatocellular carcinoma (sHCC) is a special subtype of HCC with the maximum tumor diameter ≤ 3 cm and excellent long-term outcomes. Surgical resection or radiofrequency ablation provides the greatest chance for cure; however, many patients still undergo tumor recurrence after primary treatment. To date, there is no clinical applicable method to assess biological aggressiveness in solitary sHCC. In the current study, we retrospectively evaluated tumor necrosis of 335 patients with solitary sHCC treated with hepatectomy between December 1998 and 2010 from Sun Yat-sen University Cancer Center. The presence of tumor necrosis was observed in 157 of 335 (46.9%) sHCC patients. Further correlation analysis showed that tumor necrosis was significantly correlated with tumor size and vascular invasion (P = 0.026, 0.003, respectively). The presence of tumor necrosis was associated closely with poorer cancer-specific overall survival (OS) and recurrence-free survival (RFS) as evidenced by univariate (P 
doi_str_mv 10.1186/s12885-020-07097-5
format Article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_gale_infotracacademiconefile_A628212453</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A628212453</galeid><doaj_id>oai_doaj_org_article_e744c80b225545d4894c93830305c5b3</doaj_id><sourcerecordid>A628212453</sourcerecordid><originalsourceid>FETCH-LOGICAL-c628t-b71bcfbe4af7dbbb6634a0e3ff0f7b6b7b0ea931aab2eb91038aff09566dc8183</originalsourceid><addsrcrecordid>eNptUl2L1DAULaK46-of8EEKguhD13y1SV-EZfFjYEHQ9TncpOlMlrapSTrqmz_dOzvrMiOSQsK5557eezhF8ZySc0pV8zZRplRdEUYqIkkrq_pBcUqFpBUTRD48eJ8UT1K6IYRKRdTj4oSzhhDWytPi9_UyhlhOzsaQfCoBv3IOCM0xrKeQsrf4dJ23GcEwYTHlMLsI2W9dmZa49VsYytCXM0Juyqn84fOmTGHwGeKvMo0wDOXGYTlYNwzLALG0EK2fwghPi0c9DMk9u7vPim8f3l9ffqquPn9cXV5cVbZhKldGUmN74wT0sjPGNA0XQBzve9JL0xhpiIOWUwDDnGkp4Qqw1tZN01lFFT8rVnvdLsCNnqMfcTYdwOtbIMS1hojLDk47KYRVxDBW16LuhGqFbbnihJPa1oaj1ru91ryY0XUWl44wHIkeVya_0euw1ZKzmiiBAq_vBGL4vriU9ejTzhuYXFiSZoK2ROEYDVJf_kO9CUuc0CpkMSFRkh-w1oAL-KkP-F-7E9UX6B-jTNS7uc__w8LTudHbMLneI37U8OaoATnZ_cxrWFLSq69fjrmvDrgbB0PeYAaW7MOUjolsT9xFLkXX3xtHid4FW--DrTHY-jbYusamF4eW37f8TTL_A9bJ9Ew</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2424773236</pqid></control><display><type>article</type><title>Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central</source><source>EZB Electronic Journals Library</source><source>SpringerLink Journals - AutoHoldings</source><source>PubMed Central Open Access</source><source>Springer Nature OA Free Journals</source><creator>Ling, Yi-Hong ; Chen, Jie-Wei ; Wen, Shi-Hong ; Huang, Chao-Yun ; Li, Peng ; Lu, Liang-He ; Mei, Jie ; Li, Shao-Hua ; Wei, Wei ; Cai, Mu-Yan ; Guo, Rong-Ping</creator><creatorcontrib>Ling, Yi-Hong ; Chen, Jie-Wei ; Wen, Shi-Hong ; Huang, Chao-Yun ; Li, Peng ; Lu, Liang-He ; Mei, Jie ; Li, Shao-Hua ; Wei, Wei ; Cai, Mu-Yan ; Guo, Rong-Ping</creatorcontrib><description>Small hepatocellular carcinoma (sHCC) is a special subtype of HCC with the maximum tumor diameter ≤ 3 cm and excellent long-term outcomes. Surgical resection or radiofrequency ablation provides the greatest chance for cure; however, many patients still undergo tumor recurrence after primary treatment. To date, there is no clinical applicable method to assess biological aggressiveness in solitary sHCC. In the current study, we retrospectively evaluated tumor necrosis of 335 patients with solitary sHCC treated with hepatectomy between December 1998 and 2010 from Sun Yat-sen University Cancer Center. The presence of tumor necrosis was observed in 157 of 335 (46.9%) sHCC patients. Further correlation analysis showed that tumor necrosis was significantly correlated with tumor size and vascular invasion (P = 0.026, 0.003, respectively). The presence of tumor necrosis was associated closely with poorer cancer-specific overall survival (OS) and recurrence-free survival (RFS) as evidenced by univariate (P &lt;  0.001; hazard ratio, 2.821; 95% CI, 1.643-4.842) and multivariate analysis (P = 0.005; hazard ratio, 2.208; 95% CI, 1.272-3.833). Notably, the combined model by tumor necrosis, vascular invasion and tumor size can significantly stratify the risk for RFS and OS and improve the ability to discriminate sHCC patients' outcomes (P &lt;  0.0001 for both). Our results provide evidence that tumor necrosis has the potential to be a parameter for cancer aggressiveness in solitary sHCC. The combined prognostic model may be a useful tool to identify solitary sHCC patients with worse outcomes.</description><identifier>ISSN: 1471-2407</identifier><identifier>EISSN: 1471-2407</identifier><identifier>DOI: 10.1186/s12885-020-07097-5</identifier><identifier>PMID: 32600297</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Ablation ; Ablation (Surgery) ; Cancer therapies ; Carcinoma, Hepatocellular - mortality ; Carcinoma, Hepatocellular - pathology ; Carcinoma, Hepatocellular - surgery ; Care and treatment ; Correlation analysis ; Disease-Free Survival ; Feasibility Studies ; Female ; Follow-Up Studies ; Hepatectomy ; Hepatitis ; Hepatocellular carcinoma ; Humans ; Hypoxia ; Liver - pathology ; Liver - surgery ; Liver cancer ; Liver cirrhosis ; Liver Neoplasms - mortality ; Liver Neoplasms - pathology ; Liver Neoplasms - surgery ; Male ; Medical prognosis ; Metastasis ; Middle Aged ; Models, Statistical ; Multivariate analysis ; Necrosis ; Necrosis - epidemiology ; Necrosis - pathology ; Neoplasm Invasiveness - pathology ; Neoplasm Recurrence, Local - epidemiology ; Patient outcomes ; Patients ; Prognosis ; Radiofrequency ablation ; Recurrence (Disease) ; Retrospective Studies ; Risk Assessment - methods ; Risk Factors ; Small hepatocellular carcinoma ; Statistical analysis ; Survival ; Tumor Burden ; Tumor necrosis ; Tumors</subject><ispartof>BMC cancer, 2020-06, Vol.20 (1), p.607-607, Article 607</ispartof><rights>COPYRIGHT 2020 BioMed Central Ltd.</rights><rights>2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c628t-b71bcfbe4af7dbbb6634a0e3ff0f7b6b7b0ea931aab2eb91038aff09566dc8183</citedby><cites>FETCH-LOGICAL-c628t-b71bcfbe4af7dbbb6634a0e3ff0f7b6b7b0ea931aab2eb91038aff09566dc8183</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325084/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325084/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32600297$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ling, Yi-Hong</creatorcontrib><creatorcontrib>Chen, Jie-Wei</creatorcontrib><creatorcontrib>Wen, Shi-Hong</creatorcontrib><creatorcontrib>Huang, Chao-Yun</creatorcontrib><creatorcontrib>Li, Peng</creatorcontrib><creatorcontrib>Lu, Liang-He</creatorcontrib><creatorcontrib>Mei, Jie</creatorcontrib><creatorcontrib>Li, Shao-Hua</creatorcontrib><creatorcontrib>Wei, Wei</creatorcontrib><creatorcontrib>Cai, Mu-Yan</creatorcontrib><creatorcontrib>Guo, Rong-Ping</creatorcontrib><title>Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma</title><title>BMC cancer</title><addtitle>BMC Cancer</addtitle><description>Small hepatocellular carcinoma (sHCC) is a special subtype of HCC with the maximum tumor diameter ≤ 3 cm and excellent long-term outcomes. Surgical resection or radiofrequency ablation provides the greatest chance for cure; however, many patients still undergo tumor recurrence after primary treatment. To date, there is no clinical applicable method to assess biological aggressiveness in solitary sHCC. In the current study, we retrospectively evaluated tumor necrosis of 335 patients with solitary sHCC treated with hepatectomy between December 1998 and 2010 from Sun Yat-sen University Cancer Center. The presence of tumor necrosis was observed in 157 of 335 (46.9%) sHCC patients. Further correlation analysis showed that tumor necrosis was significantly correlated with tumor size and vascular invasion (P = 0.026, 0.003, respectively). The presence of tumor necrosis was associated closely with poorer cancer-specific overall survival (OS) and recurrence-free survival (RFS) as evidenced by univariate (P &lt;  0.001; hazard ratio, 2.821; 95% CI, 1.643-4.842) and multivariate analysis (P = 0.005; hazard ratio, 2.208; 95% CI, 1.272-3.833). Notably, the combined model by tumor necrosis, vascular invasion and tumor size can significantly stratify the risk for RFS and OS and improve the ability to discriminate sHCC patients' outcomes (P &lt;  0.0001 for both). Our results provide evidence that tumor necrosis has the potential to be a parameter for cancer aggressiveness in solitary sHCC. The combined prognostic model may be a useful tool to identify solitary sHCC patients with worse outcomes.</description><subject>Ablation</subject><subject>Ablation (Surgery)</subject><subject>Cancer therapies</subject><subject>Carcinoma, Hepatocellular - mortality</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Carcinoma, Hepatocellular - surgery</subject><subject>Care and treatment</subject><subject>Correlation analysis</subject><subject>Disease-Free Survival</subject><subject>Feasibility Studies</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Hepatectomy</subject><subject>Hepatitis</subject><subject>Hepatocellular carcinoma</subject><subject>Humans</subject><subject>Hypoxia</subject><subject>Liver - pathology</subject><subject>Liver - surgery</subject><subject>Liver cancer</subject><subject>Liver cirrhosis</subject><subject>Liver Neoplasms - mortality</subject><subject>Liver Neoplasms - pathology</subject><subject>Liver Neoplasms - surgery</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Metastasis</subject><subject>Middle Aged</subject><subject>Models, Statistical</subject><subject>Multivariate analysis</subject><subject>Necrosis</subject><subject>Necrosis - epidemiology</subject><subject>Necrosis - pathology</subject><subject>Neoplasm Invasiveness - pathology</subject><subject>Neoplasm Recurrence, Local - epidemiology</subject><subject>Patient outcomes</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Radiofrequency ablation</subject><subject>Recurrence (Disease)</subject><subject>Retrospective Studies</subject><subject>Risk Assessment - methods</subject><subject>Risk Factors</subject><subject>Small hepatocellular carcinoma</subject><subject>Statistical analysis</subject><subject>Survival</subject><subject>Tumor Burden</subject><subject>Tumor necrosis</subject><subject>Tumors</subject><issn>1471-2407</issn><issn>1471-2407</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>DOA</sourceid><recordid>eNptUl2L1DAULaK46-of8EEKguhD13y1SV-EZfFjYEHQ9TncpOlMlrapSTrqmz_dOzvrMiOSQsK5557eezhF8ZySc0pV8zZRplRdEUYqIkkrq_pBcUqFpBUTRD48eJ8UT1K6IYRKRdTj4oSzhhDWytPi9_UyhlhOzsaQfCoBv3IOCM0xrKeQsrf4dJ23GcEwYTHlMLsI2W9dmZa49VsYytCXM0Juyqn84fOmTGHwGeKvMo0wDOXGYTlYNwzLALG0EK2fwghPi0c9DMk9u7vPim8f3l9ffqquPn9cXV5cVbZhKldGUmN74wT0sjPGNA0XQBzve9JL0xhpiIOWUwDDnGkp4Qqw1tZN01lFFT8rVnvdLsCNnqMfcTYdwOtbIMS1hojLDk47KYRVxDBW16LuhGqFbbnihJPa1oaj1ru91ryY0XUWl44wHIkeVya_0euw1ZKzmiiBAq_vBGL4vriU9ejTzhuYXFiSZoK2ROEYDVJf_kO9CUuc0CpkMSFRkh-w1oAL-KkP-F-7E9UX6B-jTNS7uc__w8LTudHbMLneI37U8OaoATnZ_cxrWFLSq69fjrmvDrgbB0PeYAaW7MOUjolsT9xFLkXX3xtHid4FW--DrTHY-jbYusamF4eW37f8TTL_A9bJ9Ew</recordid><startdate>20200629</startdate><enddate>20200629</enddate><creator>Ling, Yi-Hong</creator><creator>Chen, Jie-Wei</creator><creator>Wen, Shi-Hong</creator><creator>Huang, Chao-Yun</creator><creator>Li, Peng</creator><creator>Lu, Liang-He</creator><creator>Mei, Jie</creator><creator>Li, Shao-Hua</creator><creator>Wei, Wei</creator><creator>Cai, Mu-Yan</creator><creator>Guo, Rong-Ping</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20200629</creationdate><title>Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma</title><author>Ling, Yi-Hong ; Chen, Jie-Wei ; Wen, Shi-Hong ; Huang, Chao-Yun ; Li, Peng ; Lu, Liang-He ; Mei, Jie ; Li, Shao-Hua ; Wei, Wei ; Cai, Mu-Yan ; Guo, Rong-Ping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c628t-b71bcfbe4af7dbbb6634a0e3ff0f7b6b7b0ea931aab2eb91038aff09566dc8183</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Ablation</topic><topic>Ablation (Surgery)</topic><topic>Cancer therapies</topic><topic>Carcinoma, Hepatocellular - mortality</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Carcinoma, Hepatocellular - surgery</topic><topic>Care and treatment</topic><topic>Correlation analysis</topic><topic>Disease-Free Survival</topic><topic>Feasibility Studies</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Hepatectomy</topic><topic>Hepatitis</topic><topic>Hepatocellular carcinoma</topic><topic>Humans</topic><topic>Hypoxia</topic><topic>Liver - pathology</topic><topic>Liver - surgery</topic><topic>Liver cancer</topic><topic>Liver cirrhosis</topic><topic>Liver Neoplasms - mortality</topic><topic>Liver Neoplasms - pathology</topic><topic>Liver Neoplasms - surgery</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Metastasis</topic><topic>Middle Aged</topic><topic>Models, Statistical</topic><topic>Multivariate analysis</topic><topic>Necrosis</topic><topic>Necrosis - epidemiology</topic><topic>Necrosis - pathology</topic><topic>Neoplasm Invasiveness - pathology</topic><topic>Neoplasm Recurrence, Local - epidemiology</topic><topic>Patient outcomes</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Radiofrequency ablation</topic><topic>Recurrence (Disease)</topic><topic>Retrospective Studies</topic><topic>Risk Assessment - methods</topic><topic>Risk Factors</topic><topic>Small hepatocellular carcinoma</topic><topic>Statistical analysis</topic><topic>Survival</topic><topic>Tumor Burden</topic><topic>Tumor necrosis</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ling, Yi-Hong</creatorcontrib><creatorcontrib>Chen, Jie-Wei</creatorcontrib><creatorcontrib>Wen, Shi-Hong</creatorcontrib><creatorcontrib>Huang, Chao-Yun</creatorcontrib><creatorcontrib>Li, Peng</creatorcontrib><creatorcontrib>Lu, Liang-He</creatorcontrib><creatorcontrib>Mei, Jie</creatorcontrib><creatorcontrib>Li, Shao-Hua</creatorcontrib><creatorcontrib>Wei, Wei</creatorcontrib><creatorcontrib>Cai, Mu-Yan</creatorcontrib><creatorcontrib>Guo, Rong-Ping</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Proquest Health and Medical Complete</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>BMC cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ling, Yi-Hong</au><au>Chen, Jie-Wei</au><au>Wen, Shi-Hong</au><au>Huang, Chao-Yun</au><au>Li, Peng</au><au>Lu, Liang-He</au><au>Mei, Jie</au><au>Li, Shao-Hua</au><au>Wei, Wei</au><au>Cai, Mu-Yan</au><au>Guo, Rong-Ping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma</atitle><jtitle>BMC cancer</jtitle><addtitle>BMC Cancer</addtitle><date>2020-06-29</date><risdate>2020</risdate><volume>20</volume><issue>1</issue><spage>607</spage><epage>607</epage><pages>607-607</pages><artnum>607</artnum><issn>1471-2407</issn><eissn>1471-2407</eissn><abstract>Small hepatocellular carcinoma (sHCC) is a special subtype of HCC with the maximum tumor diameter ≤ 3 cm and excellent long-term outcomes. Surgical resection or radiofrequency ablation provides the greatest chance for cure; however, many patients still undergo tumor recurrence after primary treatment. To date, there is no clinical applicable method to assess biological aggressiveness in solitary sHCC. In the current study, we retrospectively evaluated tumor necrosis of 335 patients with solitary sHCC treated with hepatectomy between December 1998 and 2010 from Sun Yat-sen University Cancer Center. The presence of tumor necrosis was observed in 157 of 335 (46.9%) sHCC patients. Further correlation analysis showed that tumor necrosis was significantly correlated with tumor size and vascular invasion (P = 0.026, 0.003, respectively). The presence of tumor necrosis was associated closely with poorer cancer-specific overall survival (OS) and recurrence-free survival (RFS) as evidenced by univariate (P &lt;  0.001; hazard ratio, 2.821; 95% CI, 1.643-4.842) and multivariate analysis (P = 0.005; hazard ratio, 2.208; 95% CI, 1.272-3.833). Notably, the combined model by tumor necrosis, vascular invasion and tumor size can significantly stratify the risk for RFS and OS and improve the ability to discriminate sHCC patients' outcomes (P &lt;  0.0001 for both). Our results provide evidence that tumor necrosis has the potential to be a parameter for cancer aggressiveness in solitary sHCC. The combined prognostic model may be a useful tool to identify solitary sHCC patients with worse outcomes.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>32600297</pmid><doi>10.1186/s12885-020-07097-5</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-2407
ispartof BMC cancer, 2020-06, Vol.20 (1), p.607-607, Article 607
issn 1471-2407
1471-2407
language eng
recordid cdi_gale_infotracacademiconefile_A628212453
source MEDLINE; DOAJ Directory of Open Access Journals; PubMed Central; EZB Electronic Journals Library; SpringerLink Journals - AutoHoldings; PubMed Central Open Access; Springer Nature OA Free Journals
subjects Ablation
Ablation (Surgery)
Cancer therapies
Carcinoma, Hepatocellular - mortality
Carcinoma, Hepatocellular - pathology
Carcinoma, Hepatocellular - surgery
Care and treatment
Correlation analysis
Disease-Free Survival
Feasibility Studies
Female
Follow-Up Studies
Hepatectomy
Hepatitis
Hepatocellular carcinoma
Humans
Hypoxia
Liver - pathology
Liver - surgery
Liver cancer
Liver cirrhosis
Liver Neoplasms - mortality
Liver Neoplasms - pathology
Liver Neoplasms - surgery
Male
Medical prognosis
Metastasis
Middle Aged
Models, Statistical
Multivariate analysis
Necrosis
Necrosis - epidemiology
Necrosis - pathology
Neoplasm Invasiveness - pathology
Neoplasm Recurrence, Local - epidemiology
Patient outcomes
Patients
Prognosis
Radiofrequency ablation
Recurrence (Disease)
Retrospective Studies
Risk Assessment - methods
Risk Factors
Small hepatocellular carcinoma
Statistical analysis
Survival
Tumor Burden
Tumor necrosis
Tumors
title Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T17%3A12%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tumor%20necrosis%20as%20a%20poor%20prognostic%20predictor%20on%20postoperative%20survival%20of%20patients%20with%20solitary%20small%20hepatocellular%20carcinoma&rft.jtitle=BMC%20cancer&rft.au=Ling,%20Yi-Hong&rft.date=2020-06-29&rft.volume=20&rft.issue=1&rft.spage=607&rft.epage=607&rft.pages=607-607&rft.artnum=607&rft.issn=1471-2407&rft.eissn=1471-2407&rft_id=info:doi/10.1186/s12885-020-07097-5&rft_dat=%3Cgale_doaj_%3EA628212453%3C/gale_doaj_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2424773236&rft_id=info:pmid/32600297&rft_galeid=A628212453&rft_doaj_id=oai_doaj_org_article_e744c80b225545d4894c93830305c5b3&rfr_iscdi=true